James Michael Edwards - 05 Nov 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
VP and CFO
Signature
/s/ Maria Zannes, as attorney-in-fact for James Michael Edwards
Issuer symbol
BIAF
Transactions as of
05 Nov 2024
Transactions value $
$0
Form type
4
Filing time
05 Nov 2024, 19:05:50 UTC
Previous filing
20 Sep 2024
Next filing
14 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $0 +100K +716.54% $0.00 114K 05 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares, which shares will vest 25% on each of (1) the grant date, (2) the one year anniversary of the grant date, (3) the two year anniversary of the grant date and (4) the three year anniversary of the grant date.